Table of Contents

1 Study Coverage

• 1.1 Clofarabine Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Clofarabine Market Size Growth Rate by Product
  • 1.4.2 Evoltra
  • 1.4.3 Clolar
• 1.5 Market by End User
  • 1.5.1 Global Clofarabine Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Pharmacy
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Clofarabine Market Size
  • 2.1.1 Global Clofarabine Revenue 2014-2025
  • 2.1.2 Global Clofarabine Sales 2014-2025
• 2.2 Clofarabine Growth Rate by Regions
  • 2.2.1 Global Clofarabine Sales by Regions
  • 2.2.2 Global Clofarabine Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Clofarabine Sales by Manufacturers
  • 3.1.1 Clofarabine Sales by Manufacturers
  • 3.1.2 Clofarabine Sales Market Share by Manufacturers
  • 3.1.3 Global Clofarabine Market Concentration Ratio (CR5 and HHI)
• 3.2 Clofarabine Revenue by Manufacturers
  • 3.2.1 Clofarabine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Clofarabine Revenue Share by Manufacturers (2014-2019)
• 3.3 Clofarabine Price by Manufacturers
• 3.4 Clofarabine Manufacturing Base Distribution, Product Types
  • 3.4.1 Clofarabine Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Clofarabine Product Type
  • 3.4.3 Date of International Manufacturers Enter into Clofarabine Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Clofarabine Sales by Product
• 4.2 Global Clofarabine Revenue by Product
• 4.3 Clofarabine Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Clofarabine Breakdown Data by End User

6 North America

• 6.1 North America Clofarabine by Countries
  • 6.1.1 North America Clofarabine Sales by Countries
  • 6.1.2 North America Clofarabine Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Clofarabine by Product
• 6.3 North America Clofarabine by End User

7 Europe

• 7.1 Europe Clofarabine by Countries
  • 7.1.1 Europe Clofarabine Sales by Countries
  • 7.1.2 Europe Clofarabine Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Clofarabine by Product
• 7.3 Europe Clofarabine by End User

8 Asia Pacific

• 8.1 Asia Pacific Clofarabine by Countries
  • 8.1.1 Asia Pacific Clofarabine Sales by Countries
  • 8.1.2 Asia Pacific Clofarabine Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Clofarabine by Product
• 8.3 Asia Pacific Clofarabine by End User

9 Central & South America

• 9.1 Central & South America Clofarabine by Countries
  • 9.1.1 Central & South America Clofarabine Sales by Countries
  • 9.1.2 Central & South America Clofarabine Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Clofarabine by Product
• 9.3 Central & South America Clofarabine by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Clofarabine by Countries
  • 10.1.1 Middle East and Africa Clofarabine Sales by Countries
  • 10.1.2 Middle East and Africa Clofarabine Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Clofarabine by Product
• 10.3 Middle East and Africa Clofarabine by End User

11 Company Profiles

• 11.1 Genzyme Corporation
  • 11.1.1 Genzyme Corporation Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Genzyme Corporation Clofarabine Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Genzyme Corporation Clofarabine Products Offered
  • 11.1.5 Genzyme Corporation Recent Development

12 Future Forecast

• 12.1 Clofarabine Market Forecast by Regions
  • 12.1.1 Global Clofarabine Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Clofarabine Revenue Forecast by Regions 2019-2025
• 12.2 Clofarabine Market Forecast by Product
  • 12.2.1 Global Clofarabine Sales Forecast by Product 2019-2025
  • 12.2.2 Global Clofarabine Revenue Forecast by Product 2019-2025
• 12.3 Clofarabine Market Forecast by End User
• 12.4 North America Clofarabine Forecast
• 12.5 Europe Clofarabine Forecast
• 12.6 Asia Pacific Clofarabine Forecast
• 12.7 Central & South America Clofarabine Forecast
• 12.8 Middle East and Africa Clofarabine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Clofarabine Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Clofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra.
The global Clofarabine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Clofarabine market based on company, product type, end user and key regions.

This report studies the global market size of Clofarabine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Clofarabine in these regions.
This research report categorizes the global Clofarabine market by top players/brands, region, type and end user. This report also studies the global Clofarabine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Genzyme Corporation

Market size by Product
Evoltra
Clolar
Market size by End User
Hospital
Pharmacy

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Clofarabine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Clofarabine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Clofarabine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Clofarabine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Clofarabine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Clofarabine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.